Journal
BLOOD
Volume 134, Issue 2, Pages 97-98Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2019001189
Keywords
-
Categories
Ask authors/readers for more resources
In this issue of Blood, Roberts et al expand our understanding of prognostic biomarkers predicting the duration of remission in relapsed/refractory chronic lymphocytic leukemia (CLL) treated with venetoclax.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
